http://www.cancerci.com/content/9/1/9
Pegylated derivatives of recombinant human arginase (rhArg1) for sustained in vivo activity in cancer therapy: preparation, characterization and analysis of their pharmacodynamics in vivo and in vitro and action upon hepatocellular carcinoma cell (HCC)
HEPATOCELLULAR LIVER CANCER
4.10.2009
http://www.biomedcentral.com/1471-2407/9/46
Survival and hepatitis status among Asian Americans with hepatocellular carcinoma treated without liver transplantation
ALPHA-FETOPROTEIN HEPATITIS HEPATOCELLULAR LIVER CANCER
3.3.2008
http://www.jeccr.com/content/28/1/111
Subcellular localization of APMCF1 and its biological significance of expression pattern in normal and malignant human tissues
HEPATOCARCINOMA TUMOR LIVER MALIGNANT
4.10.2009
http://www.jeccr.com/content/28/1/122
Proteomic analysis of differentially expressed proteins in hepatitis B virus-related hepatocellular carcinoma tissues
HEPATITIS HEPATOCELLULAR LIVER CANCER
4.10.2009
http://www.jeccr.com/content/28/1/112
Traditional Chinese medicines in the treatment of hepatocellular cancers: a systematic review and meta-analysis
HEPATOCELLULAR LIVER CANCER
4.10.2009
http://www.biomedcentral.com/1471-2407/9/271
A proteomic strategy to identify novel serum biomarkers for liver cirrhosis and hepatocellular cancer in individuals with fatty liver disease.
LIVER HEPATOCELLULAR CANCER
4.10.2009
http://www.jeccr.com/content/28/1/80
Preventive effect of the flavonoid, quercetin, on hepatic cancer in rats via oxidant/antioxidant activity: molecular and histological evidences
HEPATOCELLULAR LIVER CANCER
4.10.2009
http://www.biomedcentral.com/1471-2407/9/65
Differential expression of Caveolin-1 in hepatocellular carcinoma: correlation with differentiation state, motility and invasion
HEPATOCELLULAR TUMOR LIVER CANCER
4.10.2009
http://www.casesjournal.com/content/2/1/3
An unusual cause of dysphagia in ductal breast cancer due to submucosal oropharyngeal metastatic spread: a case report
LIVER CARCINOMA CANCER
4.10.2009
http://www.biomedcentral.com/1755-8794/2/5
Gene expression profile analysis of human hepatocellular carcinoma using SAGE and LongSAGE
HEPATOCELLULAR LIVER CANCER
4.10.2009
http://www.biomedcentral.com/1471-2407/9/33
Early and very early hepatocellular carcinoma: when and how much do staging and choice of treatment really matter? A multi-center study.
HEPATOCELLULAR LIVER CANCER
4.10.2009
http://www.physorg.com/news169301759.html
Sequential TACE and cryosurgery can improve survival times for patients with HCC?
HCC LIVER TACE CARCINOMA CANCERS
4.10.2009
http://www.biomedcentral.com/1471-2407/9/208
Early MRI response monitoring of patients with advanced hepatocellular carcinoma under treatment with the multikinase inhibitor sorafenib
HEPATOCELLULAR LIVER TUMOR
4.10.2009
http://www.jeccr.com/content/28/1/58
Role of hepatitis B surface antigen in the development of hepatocellular carcinoma: regulation of lymphoid enhancer-binding factor 1
HEPATITIS HEPATOCELLULAR LIVER TUMOR
4.10.2009
http://www.jeccr.com/content/28/1/20
Expression of nicotinamide N-methyltransferase in hepatocellular carcinoma is associated with poor prognosis
HEPATOCELLULAR TUMOR LIVER
4.10.2009
http://www.biomedcentral.com/1471-2407/8/392
Quantification of SLIT-ROBO transcripts in hepatocellular carcinoma reveals two groups of genes with coordinate expression
HEPATOCELLULAR TUMOR LIVER CANCERS
4.10.2009
http://www.casesjournal.com/content/2/1/18
Development of hepatocellular carcinoma in a patient 13 years after sustained virological response to interferon against chronic hepatitis C: a case report
HEPATOCELLULAR HEPATITIS LIVER TUMOR
4.10.2009
http://www.biomedcentral.com/1471-2407/9/309
A protein-based set of reference markers for liver tissues and hepatocellular carcinoma
LIVER HEPATOCELLULAR CARCINOMA CANCEROUS
4.10.2009